Diabetes: LDL Management & Control (NQF 0064)

eMeasure Name Diabetes: LDL Management & Control eMeasure Id 2857f177-2806-4a86-a015-a359954795b5
Version number 1 eMeasure Set Id 973d4b13-04ec-4c68-a03f-66df138edeca
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward National Committee for Quality Assurance
Endorsed by National Quality Forum
Description The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had LDL-C <100mg/dL.
Copyright
© National Committee for Quality Assurance. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
This measure assesses the percentage of patients in a specific age demographic who were diagnosed with type 1 or type 2 diabetes and who demonstrate poor lowdensity lipoprotein (LDL) cholesterol levels. Diabetes mellitus (diabetes) is a group of diseases characterized by high blood glucose levels caused by the bodys inability to correctly produce or utilize the hormone insulin . It is recognized as a leading cause of death and disability in the U.S. and is highly underreported as a cause of death. Diabetes of either type may cause life-threatening, life-ending or life-altering complications, including poor cholesterol, specifically LDL. Clinical guidelines recommend lifestyle modifications that include reducing intake of saturated fat, trans fat and cholesterol; weight loss; and increased physical activity (ADA 2009). Statin therapy is suggested for eligible patients whose levels are consistently and significantly higher (ADA 2009). This measure facilitates longterm management of LDL cholesterol levels for patients diagnosed with diabetes.
Clinical Recommendation Statement
American Diabetes Association: In most adult patients, measure fasting lipid profile at least annually. In adults with low-risk lipid values (LDL cholesterol < 100 mg/dl, HDL cholesterol > 50 mg/dl, and triglycerides < 150 mg/dl), lipid assessments may be repeated every 2 years.
                
ACE/AACE: Aggressive management of dyslipidemia in patients with diabetes mellitus is critical; treat patients to achieve the following goal: LDL-C < 100 mg/dL (< 70 mg/dL is recommended for patients with diabetes mellitus and coronary artery disease).
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
Standards of Medical Care in Diabetes - 2009. Diabetes Care January 2009 32:S6-S12; doi:10.2337/dc09S006
Reference
AACE Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus. Endocrine Practice Vol 13 (Suppl 1) May/June 2007
Definition
Initial Patient Population(s): All patients 18 to 75 years of age during the measurement period
Definition
Denominator(s): Patients in the initial population with a diagnosis of diabetes and at least 2 non-acute inpatient or outpatient encounters, or currently receiving medications indicative of diabetes during the measurement period or in the 12 months prior to the measurement period
Definition
Denominator Exception(s): N/A
Definition
Numerator(s): 
N1: The number of patients who have had a low density lipoprotein cholesterol (LDL)-C test performed during the measurement period
N2: The number of patients with a LDL-C level <100 mg/dL during the measurement period.
Definition
Denominator Exclusion(s): Patients with a diagnosis of polycystic ovaries, gestational diabetes or steroid-induced diabetes who did not have any face-to-face encounters in any setting, with a diagnosis of diabetes, during the measurement period or the 12 months prior to the measurement period
Guidance
The measure expects an LDL test result (Numerator 1) and an LDL value < 100 mg/dL (Numerator 2).
Supplemental Data Elements
Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Supplemental Data Elements




Measure set CLINICAL QUALITY MEASURE SET 2011-2012